(Q36523260)

14 August 2017

1 reference

title

Heart failure induced by non-cardiac drugs (English)

1 reference

14 August 2017

1 reference

2

Olav Spigset

1 reference

14 August 2017

1

Lars Slørdal

1 reference

14 August 2017

publication date

1 January 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

29

1 reference

14 August 2017

issue

7

1 reference

14 August 2017

page(s)

567-586

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-200629070-00003

14 August 2017

exact match

0 references

cites work

Risk factors for doxorubicin-induced congestive heart failure

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200629070-00003

Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200629070-00003

Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200629070-00003

Non-steroidal anti-inflammatory drugs and hypertension in the elderly: a community-based cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200629070-00003

Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200629070-00003

Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200629070-00003

Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200629070-00003

Case reports of heart failure after therapy with a tumor necrosis factor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200629070-00003

Fenfluramine and phentermine and cardiovascular findings: effect of treatment duration on prevalence of valve abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200629070-00003

Heart valvular disease in patients with Parkinson’s disease treated with high-dose pergolide

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200629070-00003

Cardiovascular effects of fluoxetine in depressed patients with heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200629070-00003

Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200629070-00003

Safer use of traditional remedies. Remedies may contain cocktail of active drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200629070-00003

How natural are 'natural herbal remedies'? A Saudi perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002018-200629070-00003

NSAIDs and blood pressure. Clinical importance for older patients

21 January 2018

1 reference

12 December 2020

The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia

1 reference

12 December 2020

Rosiglitazone (Avandia) and pioglitazone (Actos) and heart failure.

1 reference

12 December 2020

Profound neonatal congestive heart failure caused by maternal consumption of blue cohosh herbal medication.

1 reference

12 December 2020

Tricyclics and heart failure

1 reference

12 December 2020

Effect of imipramine and nortriptyline on left ventricular function and blood pressure in patients treated for arrhythmias

1 reference

12 December 2020

Cardiac issues related to trastuzumab

1 reference

12 December 2020

Chemotherapy-induced cardiotoxicity: current practice and prospects of prophylaxis

1 reference

12 December 2020

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

1 reference

12 December 2020

Severe multivalvular heart disease: a new complication of the ergot derivative dopamine agonists

1 reference

12 December 2020

Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials

1 reference

12 December 2020

The current and future role of dexrazoxane as a cardioprotectant in anthracycline treatment: expert panel review.

1 reference

12 December 2020

1 reference

12 December 2020

Cardiac dysfunction in the trastuzumab clinical trials experience

1 reference

12 December 2020

Use of nonsteroidal anti-inflammatory drugs and the risk of first-time acute myocardial infarction

1 reference

12 December 2020

Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy

1 reference

12 December 2020

Does altered glucocorticoid homeostasis increase cardiovascular risk?

1 reference

12 December 2020

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

1 reference

12 December 2020

Cardiotoxicity as a dose-limiting factor in a schedule of high dose bolus therapy with interleukin-2 and alpha-interferon. An unexpectedly frequent complication

1 reference

12 December 2020

Valvular abnormalities and cardiovascular status following exposure to dexfenfluramine or phentermine/fenfluramine

1 reference

12 December 2020

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

1 reference

12 December 2020

Cardiotoxicity of tricyclic antidepressants in primary cultures of rat myocardial cells

1 reference

12 December 2020

Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography

1 reference

12 December 2020

Cardiovascular toxicity with cancer chemotherapy

1 reference

12 December 2020

A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure

1 reference

12 December 2020

Nonsteroidal antiinflammatory drugs as a trigger of clinical heart failure

1 reference

12 December 2020

Idiopathic giant cell myocarditis after autologous hematopoietic stem cell transplantation and interleukin-2 immunotherapy: a case report

1 reference

12 December 2020

Adverse cardiovascular effects of NSAIDs in patients with congestive heart failure

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drug use and acute myocardial infarction

1 reference

12 December 2020

Constrictive pericarditis and pleuropulmonary fibrosis secondary to cabergoline treatment for Parkinson's disease

1 reference

12 December 2020

Cardiotoxicity of human recombinant interleukin-2 in rats. A morphological study

1 reference

12 December 2020

Amphotericin B-induced dilated cardiomyopathy

1 reference

12 December 2020

Reduced cardiotoxicity of doxorubicin by a 6-hour infusion regimen. A prospective randomized evaluation

1 reference

12 December 2020

A comparison of liposomal formulations of doxorubicin with drug administered in free form: changing toxicity profiles

1 reference

12 December 2020

Valvular heart disease in patients taking pergolide

1 reference

12 December 2020

Myocarditis or acute myocardial infarction associated with interleukin-2 therapy for cancer

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drugs and heart failure

1 reference

12 December 2020

Cardiac toxicity 4 to 20 years after completing anthracycline therapy

1 reference

12 December 2020

Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study

1 reference

12 December 2020

Doxorubicin administration by continuous infusion is not cardioprotective: the Dana-Farber 91-01 Acute Lymphoblastic Leukemia protocol

1 reference

12 December 2020

Cardiac safety of liposomal anthracyclines

1 reference

12 December 2020

Decreased cardiac toxicity of doxorubicin administered by continuous intravenous infusion in combination chemotherapy for metastatic breast carcinoma

1 reference

12 December 2020

Reversal of Phen-Fen associated valvular regurgitation documented by serial echocardiography

1 reference

12 December 2020

Effects of nonsteroidal anti-inflammatory drug therapy on blood pressure and peripheral edema

1 reference

12 December 2020

Cardiotoxicity of cytotoxic drugs

1 reference

12 December 2020

Reversible cardiac dysfunction associated with interferon alfa therapy in AIDS patients with Kaposi's sarcoma

1 reference

12 December 2020

Efficacy, safety, and cost of new anticancer drugs

1 reference

12 December 2020

Effects of sibutramine on ventricular dimensions and heart valves in obese patients during weight reduction

1 reference

12 December 2020

Does anthracycline administration by infusion in children affect late cardiotoxicity?

1 reference

12 December 2020

Cyclooxygenase-2 inhibitor treatment improves left ventricular function and mortality in a murine model of doxorubicin-induced heart failure

1 reference

12 December 2020

Spin trapping biologically generated free radicals: correlating formation with cellular injury

1 reference

12 December 2020

1 reference

12 December 2020

New oral therapies for type 2 diabetes mellitus: The glitazones or insulin sensitizers

1 reference

12 December 2020

Anthracycline-induced cardiotoxicity: clinical course, risk factors, pathogenesis, detection and prevention--review of the literature

1 reference

12 December 2020

Fluid retention after initiation of thiazolidinedione therapy in diabetic patients with established chronic heart failure

1 reference

12 December 2020

Studies on adriamycin using a weekly regimen demonstrating its clinical effectiveness and lack of cardiac toxicity

1 reference

12 December 2020

COX-2 selective nonsteroidal anti-Inflammatory drugs: do they really offer any advantages?

1 reference

12 December 2020

Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood

1 reference

12 December 2020

An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained-release dexfenfluramine, or placebo. Sustained-Release Dexfenfluramine Study Group

1 reference

12 December 2020

Overview of cardiac pathology in relation to anthracycline cardiotoxicity

1 reference

12 December 2020

Aldosterone in congestive heart failure

1 reference

12 December 2020

Serum troponin T levels and echocardiographic evaluation in children treated with doxorubicin

1 reference

12 December 2020

Drug-induced heart failure

1 reference

12 December 2020

Liquorice and its health implications

1 reference

12 December 2020

Reversible cardiomyopathy after high-dose interleukin-2 therapy

1 reference

12 December 2020

Doxorubicin-induced cardiomyopathy

1 reference

12 December 2020

Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study

1 reference

12 December 2020

Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease. Clinical evaluation with special reference to childhood leukemia

1 reference

12 December 2020

Long-term prospective follow-up study of cardiac function after cardiotoxic therapy for malignancy in children

1 reference

12 December 2020

Chinese herbal medicine: camouflaged prescription antiinflammatory drugs, corticosteroids, and lead

1 reference

12 December 2020

Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failu

1 reference

12 December 2020

COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease

1 reference

12 December 2020

The taxoids. Comparative clinical pharmacology and therapeutic potential

1 reference

12 December 2020

Predicting cancer therapy-induced cardiotoxicity: the role of troponins and other markers

1 reference

12 December 2020

Association between naproxen use and protection against acute myocardial infarction

1 reference

12 December 2020

Reversible dilated cardiomyopathy related to amphotericin B therapy

1 reference

12 December 2020

Reversible cardiomyopathy induced by interferon

1 reference

12 December 2020

"Herbal" medicines and rheumatoid arthritis

1 reference

12 December 2020

Adverse effects of corticosteroids on the cardiovascular system

1 reference

12 December 2020

Use of thiazolidinediones and risk of heart failure in people with type 2 diabetes: a retrospective cohort study

1 reference

12 December 2020

Effects of the sibutramine therapy on pulmonary artery pressure in obese patients

1 reference

12 December 2020

Epidemiology of anthracycline cardiotoxicity in children and adults.

1 reference

12 December 2020

NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics.

1 reference

12 December 2020

Prolonged monitoring of troponin T for the detection of anthracycline cardiotoxicity in adults with hematological malignancies

1 reference

12 December 2020

Cardiovascular effects and toxicity of anxiolytics and antidepressants

1 reference

12 December 2020

Appetite suppressants and valvular heart disease

1 reference

12 December 2020

Cardiotoxicity associated with trastuzumab (Herceptin) therapy in the treatment of metastatic breast cancer

1 reference

12 December 2020

Myocarditis and cardiomyopathy associated with clozapine

1 reference

12 December 2020

Clinical and echocardiographic follow-up of patients previously treated with dexfenfluramine or phentermine/fenfluramine

1 reference

12 December 2020

Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study.

1 reference

12 December 2020

Association of outpatient utilisation of non-steroidal anti-inflammatory drugs and hospitalised heart failure in the entire Swedish population

1 reference

12 December 2020

Congestive heart failure associated with itraconazole

1 reference

12 December 2020

Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications

1 reference

12 December 2020

Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention

1 reference

12 December 2020

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

12 December 2020

The cardiotoxicity of anticancer agents.

1 reference

12 December 2020

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

1 reference

12 December 2020

Long-term tri- and tetra-cyclic antidepressants, myocardial contractility, and cardiac rhythm.

1 reference

12 December 2020

Evaluation of myocardial cell damage by In-111-monoclonal antimyosin antibodies in patients under chronic tricyclic antidepressant drug treatment

1 reference

12 December 2020

Mitral and aortic valve disease associated with ergotamine therapy for migraine. Report of two cases and review of literature

1 reference

12 December 2020

Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy

1 reference

12 December 2020

Risk of cardiovascular events associated with selective COX-2 inhibitors

1 reference

12 December 2020

Reversible cardiac enlargement during treatment with amphotericin B and hydrocortisone. Report of three cases

1 reference

12 December 2020

Inhibition of cyclooxygenase-2 aggravates doxorubicin-mediated cardiac injury in vivo

1 reference

12 December 2020

Adriamycin given as a weekly schedule without a loading course: clinically effective with reduced incidence of cardiotoxicity

1 reference

12 December 2020

Glitazones and heart failure: critical appraisal for the clinician.

1 reference

12 December 2020

Anorexigens and pulmonary hypertension in the United States: results from the surveillance of North American pulmonary hypertension

1 reference

12 December 2020

Association of nonsteroidal anti-inflammatory drugs with first occurrence of heart failure and with relapsing heart failure: the Rotterdam Study

1 reference

12 December 2020

Lower risk of thromboembolic cardiovascular events with naproxen among patients with rheumatoid arthritis

1 reference

12 December 2020

Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy

1 reference

12 December 2020

Natriuretic peptides during the development of doxorubicin-induced left ventricular diastolic dysfunction

1 reference

12 December 2020

Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study.

1 reference

12 December 2020

Meta-analysis of cyclooxygenase-2 inhibitors and their effects on blood pressure

1 reference

12 December 2020

Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure

1 reference

12 December 2020

Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining study

1 reference

12 December 2020

Differences in outcomes of patients with congestive heart failure prescribed celecoxib, rofecoxib, or non-steroidal anti-inflammatory drugs: population based study

1 reference

12 December 2020

A case of reversible dilated cardiomyopathy after alpha-interferon therapy in a patient with renal cell carcinoma.

1 reference

12 December 2020

Chuei-Fong-Tou-Geu-Wan in rheumatoid arthritis

1 reference

12 December 2020

Cardiopulmonary toxicity of treatment with high dose interleukin-2 in 199 consecutive patients with metastatic melanoma or renal cell carcinoma

1 reference

12 December 2020

Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease: an observational cohort study

1 reference

12 December 2020

Pathologic findings associated with interleukin-2-based immunotherapy for cancer: a postmortem study of 19 patients

1 reference

12 December 2020

Cardiac profiles of liposomal anthracyclines: greater cardiac safety versus conventional doxorubicin?

1 reference

12 December 2020

Severe myocarditis following high-dose interleukin-2 administration

1 reference

12 December 2020

Functional monitoring of anthracycline cardiotoxicity: a prospective, blinded, long-term observational study of outcome in 120 patients

1 reference

12 December 2020

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

1 reference

12 December 2020

Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem.

1 reference

12 December 2020

Multiple myeloma complicated by congestive heart failure following first administration of recombinant alpha-interferon

1 reference

12 December 2020

Cardiotoxicity of interferon. A review of 44 cases

1 reference

12 December 2020

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

1 reference

12 December 2020

Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis

1 reference

12 December 2020

Effect of selective cyclooxygenase 2 inhibitors and naproxen on short-term risk of acute myocardial infarction in the elderly

1 reference

12 December 2020

Cardiovascular effects of tricyclic antidepressants in depressed patients with chronic heart disease

1 reference

12 December 2020

1 reference

12 December 2020

Cardiac murmurs and endocardial fibrosis associated with methysergide therapy

1 reference

12 December 2020

Licorice-induced hypermineralocorticoidism

1 reference

12 December 2020

Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group

1 reference

12 December 2020

10.2165/00002018-200629070-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

14 August 2017

1053341227

0 references

Fatcat ID

release_qxziqtfkdnaqpgkk55gi73lw5m

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qxziqtfkdnaqpgkk55gi73lw5m

24 November 2022

mapped directly with Wikidata item

1 reference